Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study
Recruiting · NCT06642831 · Observational (researchers observe without assigning treatment) · Lead sponsor: University Hospital Erlangen
View the official record on ClinicalTrials.gov →What this trial is about
The purpose of the study is to validate recently identified biomarkers for the identification of PCOS in adolecent and young adult women.
Who can take part
Age range
15 Years to 25 Years
Sex
Female
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Female subjects age 15-25 years
- Signed written informed consent
Exclusion criteria
- Less than 1 years from onset of menarche
- Use of hormonal contraceptives
- Documented ongoing pregnancy
- Major ovarian abnormalities, including subject with only one ovary, cysts and solid masses \> 2 cm as detected by transvaginal ultrasound
- Malignancy ( documented malignancy, documentation of current radiation therapy or chemotherapy in medical record)
Where it is running
1 location listed.
- Department of Obstetrics and Gynecology, University Erlangen Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany - Erlangen, Germany